What Does 99% Peptide Purity Mean?
The number is usually a chromatographic area percentage. This page explains exactly what it measures — and the several things it does not.
Direct answer
A stated purity of 99% usually means that, under a specific analytical method — most often reversed-phase HPLC with UV detection — the target peptide accounts for about 99% of the total detected peak area, with roughly 1% attributable to related impurities such as truncated or modified sequences. It is a measure of relative composition among the species the method detects, under that method's conditions. It is not a statement that the vial is 99% peptide by total mass, and it does not by itself establish identity, potency, sterility, endotoxin status, safety, or suitability for any use.
Why this matters
Purity is the most prominent number on most peptide Certificates of Analysis, and it is also the most frequently over-interpreted. Reading it correctly means knowing what it measures, what method produced it, and — just as importantly — the several distinct properties it says nothing about. This page is the Academy's primary reference for the peptide-purity concept.
What the percentage represents
Purity figures come from more than one type of analytical method, and the exact calculation depends on the method used. For chromatographic methods that use area normalization, purity may be reported as the target peak's area relative to the total integrated peak area, under the stated method and detection conditions. In this approach an HPLC instrument separates the components of the sample, the software integrates the area under each peak, and the target peak's area is expressed as a percentage of the total detected peak area:
So a 99% figure describes the principal peak's share relative to the other components the method detected. The remaining ~1% represents related components — for peptides, commonly sequences that are truncated, incompletely processed, or chemically modified.
Why the analytical method matters
Purity is method-dependent, and area normalization is a method-specific reporting approach rather than a single universal definition. Not every analytical method uses the same calculation. Even within area normalization, the result rests on assumptions: different components may not produce equal detector response for the same amount (their response factors can differ), so peak-area share is not always identical to true composition. Components that do not respond at the chosen detection wavelength, or that are not resolved from the main peak, may not be represented at all. The detection wavelength, column, mobile-phase gradient, and run conditions all shape what is detected and how well components are separated. For all of these reasons, the laboratory method must be read alongside the reported result, and a purity value is only fully meaningful in the context of its Certificate of Analysis.
Why 99% purity is not the same as 99% of vial mass
A chromatographic area percentage describes relative composition among the peptide-related species the detector responds to. It is not a measure of the total contents of the vial by weight. Materials such as residual water, counter-ions, or salts from the manufacturing process are not necessarily captured by the same measurement. The amount of actual peptide by mass is a different quantity — sometimes described as net peptide content — determined by different methods.
What purity is not: four distinctions
Much of the confusion around purity comes from conflating it with properties it does not describe.
| Purity vs… | The distinction |
|---|---|
| Identity | Purity says how much of the detected material is the main peak; it does not confirm that the main peak is the intended molecule. Identity is supported separately, usually by mass spectrometry. |
| Assay / potency | Purity is a composition measure. It does not measure quantity of active substance or any functional effect. A pure substance is not necessarily a potent or active one. |
| Net peptide content | Purity is a relative percentage among detected peaks; net peptide content is how much peptide is present by mass, accounting for non-peptide components. The two answer different questions. |
| Sterility / endotoxin | Purity by HPLC says nothing about microbial contamination or endotoxin levels. Those require dedicated tests and are not implied by any purity figure. |
What this information supports — and does not establish
What it supports
- The relative proportion of the target peptide among detected components, under the stated method.
- A basis for comparing composition between batches tested by the same method.
What it does not establish
- That the vial is 99% peptide by total mass.
- Identity, potency, or net peptide content.
- Sterility or endotoxin status.
- Safety, or suitability or appropriateness for any use, including any use in humans.
Important limitations
A purity figure reflects only the components the method detects, under its specific conditions. Components that do not respond at the chosen detection wavelength, or that co-elute with the main peak, may not be represented. Because the figure is method-dependent, values from different methods or laboratories are not always directly comparable. A purity result should be interpreted alongside its method and the full Certificate of Analysis, and never read as a statement about safety or fitness for a purpose.
Common misconception
"99% purity means the vial is 99% peptide and is high quality and safe."
Each part of that is a separate error. The figure is a chromatographic area percentage, not a mass fraction of the vial; it does not address identity, potency, or net content; and it says nothing about sterility, endotoxin status, or safety. Purity is one specific, method-bounded measurement — informative within its scope, and silent outside it.
Related terms
Related Academy lessons
- Purity vs Identity vs PotencyHow purity differs from the other two analytical concepts.
- What Is HPLC Testing?The method that produces the purity figure.
- How to Read a Peptide COAReading purity in the context of the full certificate.
- What Are Peptides?The molecules being measured.
- HPLC vs Mass SpectrometryHow the purity method compares with mass spectrometry.
Further reading & references
- ICH Harmonised Tripartite Guideline. Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (CPMP/ICH/367/96). International Council for Harmonisation. Cited here as an established pharmaceutical analytical/specification framework that informs general principles — quantitative analytical procedures, the role of reference standards, and the separate testing of distinct quality attributes. Note: ICH Q6A governs specifications for new pharmaceutical drug substances and drug products; it is referenced here only to illustrate widely accepted analytical concepts and does not apply to, or govern, research-use-only materials, which are not pharmaceutical drug substances. Available via the ICH guidelines library (ich.org).
- "High Performance Liquid Chromatography." Chemistry LibreTexts, Analytical Chemistry. Retrieved 2026. https://chem.libretexts.org/
Cite this page
Cite this Academy page in your notes or references.